What Dose of Zepbound Is Most Effective?

If you want the short, evidence-based answer: in the pivotal obesity trials, the highest maintenance dose of tirzepatide (15 mg once weekly) produced the most weight loss on average, with the 10 mg dose close behind and 5 mg clearly lower¹. But "most effective" and "best for you" are not the same thing, and treating them as identical is how people end up with worse side effects for little extra benefit. This page lays out what the dose-response data actually shows, where the curve flattens, and why the most effective dose in a trial average may not be the one your body tolerates.

A reminder before the numbers: Zepbound is the FDA-approved brand of tirzepatide for chronic weight management (Mounjaro is the same molecule approved for type 2 diabetes), it is prescription-only, and every dose figure below comes from controlled trials of the brand product — not compounded vials, which are not held to the same standards².

The approved maintenance doses are 5, 10, and 15 mg

Zepbound is started at 2.5 mg once weekly purely as a run-in to let the gut adjust; that starting dose is not a maintenance dose and isn't expected to drive much weight loss². From there the dose is raised in 2.5 mg steps, no closer than four weeks apart, with the three maintenance doses being 5, 10, and 15 mg once weekly². So the real question — "which dose works best" — is a question about those three steps.

What SURMOUNT-1 showed: weight loss rises with dose

SURMOUNT-1 was the 72-week, placebo-controlled phase 3 trial in adults with obesity (or overweight plus a weight-related condition) without diabetes. It tested all three maintenance doses head-to-head against placebo, and the dose-response was clear¹:

| Weekly maintenance dose | Mean weight change at 72 weeks | |-------------------------|--------------------------------| | 5 mg | about −15% | | 10 mg | about −19.5% | | 15 mg | about −20.9% | | Placebo | about −3.1% |

Read across that column and two things stand out. First, more dose did mean more weight loss — 15 mg beat 5 mg by roughly five to six percentage points of body weight on average¹. Second, the gap between 10 mg and 15 mg is small — on the order of a percentage point or so. The steepest gain is moving from 5 mg to 10 mg; the jump from 10 mg to 15 mg adds comparatively little to the average. That flattening at the top of the curve is the single most useful fact for thinking about "most effective."

A systematic review pooling the tirzepatide weight-loss trials reached the same shape of conclusion: efficacy increases across the dose range, and so do gastrointestinal side effects, which are dose-dependent and concentrated during dose increases³. In other words, the cost of climbing to the top of the ladder is not zero.

"Most effective" averages hide a lot of individual variation

Those trial figures are averages. Within every dose arm, some people lost far more than the mean and some far less — we unpack that spread, the responder rates, and how fast the loss accrues in Zepbound results: how much weight can you lose. A network meta-analysis comparing tirzepatide and semaglutide across doses confirmed tirzepatide's higher doses sit at the top for weight loss, but it is still reporting group-level estimates, not a guarantee for any one person⁴. Plenty of people reach their goal on 5 or 10 mg and never need 15 mg; others tolerate 15 mg well and want the extra effect. The "most effective dose" in a population average is a starting point for a conversation with a prescriber, not a target everyone should chase.

The trade-off the average doesn't show: tolerability

Effectiveness only counts if you can actually stay on the dose. The dominant Zepbound side effects are gastrointestinal — nausea, diarrhea, constipation, vomiting — and a network meta-analysis of GI adverse events across GLP-1-class drugs found these effects rise with dose and are worst during titration⁵. That is the whole reason the label mandates slow, stepped increases rather than starting high².

So the practical definition of your most effective dose is: the lowest dose that gets you to your weight goal while keeping side effects tolerable enough to stay on it long-term. For some that's 10 mg; for others it's 15 mg; for others 5 mg is plenty. A dose you quit because of nausea delivers 0% weight loss, regardless of what the trial average says. The standard clinical move when a step is poorly tolerated is to hold longer at the current dose, or step back down, rather than push through — the schedule sets a floor on speed, not a mandate to reach 15 mg². For the full titration sequence laid out as a reference, see our tirzepatide dosage chart, and for how each side-effect wave behaves at each step, our tirzepatide dosing ladder and side effects guide and the full Zepbound side effects breakdown. (Arriving from semaglutide? You restart this ladder at 2.5 mg no matter your prior dose — see switching from semaglutide to tirzepatide.) Whatever dose you settle on, the larger weight loss at higher doses also means more absolute lean-mass loss unless you protect it — see does tirzepatide cause muscle loss?.

Does a higher dose still help if you started at the bottom?

Yes — the dose-response means people who plateau on a lower dose can often gain additional loss by advancing, which is exactly why the ladder goes up to 15 mg¹. SURMOUNT-3 is instructive here: participants who had already lost weight through an intensive lifestyle program then went on tirzepatide and lost substantially more, showing the drug adds effect on top of a lower baseline⁶. And SURMOUNT-4 showed the flip side — people who stopped tirzepatide after reaching a high dose regained much of the weight, while those who continued kept it off, underlining that whatever dose works, the effect depends on staying on an effective dose, not reaching a number once⁷ — which is exactly why there's no separate lower setting once you hit goal; see Zepbound maintenance dose after goal weight.

Most effective for what? Indication matters

For obstructive sleep apnea — a separate FDA-approved Zepbound use — the trials and label center on the 10 and 15 mg maintenance doses, not the lower steps². So "most effective dose" can differ by why the drug is being used. For chronic weight management the full 5/10/15 mg range is on the table; for OSA the evidence base sits at the upper doses.

The honest bottom line

In the trial data, 15 mg once weekly produced the most weight loss, with 10 mg close behind and 5 mg lower — effectiveness genuinely rises with dose¹. But the curve flattens between 10 and 15 mg while side effects keep climbing, so the dose that's "most effective" on a chart isn't automatically the one that's most effective for you³⁵. The dose worth aiming for is the lowest one that reaches your goal and that you can comfortably stay on, decided with a prescriber — because a tolerated 10 mg beats an abandoned 15 mg every time. To weigh how to get brand Zepbound versus other routes, start with our best tirzepatide overview, and for the wider evidence picture see the tirzepatide evidence guide. Dose also drives price — the self-pay vial tiers in our Zepbound cost and savings guide explain why 7.5 mg and up cost the same flat rate. And while the dose drives results, the time of day you inject does not — see the best time and day to inject tirzepatide.